Competact prescribing information |
|
 |
|
Competact notes:
Competact (generic name Pioglitazone) known also as Metformin is used for the treatment of type 2 diabetes mellitus particularly in overweight patients, who are unable to achieve sufficient glycaemic control at their maximum tolerated dose of metformin. Diabetes leads to problem in controlling blood sugar levels. This medication containing pioglitazone hydrochloride and metformin hydrochloride helps to keep blood sugar level under control.
Competact side effects includes nausea, vomiting, diarrhoea, loss of appetite, blood in the urine, erectile dysfunction, eyesight problem, hypoaesthesia, oedema, itching, difficulty sleeping or sinusitis.
It is marketed under name of Actoplus met in United States.
The recommended dosage for Compectact is as prescribed by doctor; it is taken with or after food. If a dose is missed continue with the regular routine and do not double up the dose. Seek emergency medical attention if an overdose of this medication is detected.
Competact is available in 15 mg/850 mg dosage form, in which 15 mg is of pioglitazone and 850 mg of metformin. It is advisable not to take competact if you are allergic to any of the ingredient of competact , avoid drinking alcohol as it can worsened the side effects of this medication.
Consult doctor before taking competact if you are pregnant or planning to become pregnant during treatment. Breast feeding women should not take this medicine.
Store competact at room temperature away from the reach of children.
Diabetes Care. 2010 Jul;33(7):1484-90.
Chatterjee R et all.
Analysis showing cost reduction in screening of pre diabetes adults
Arh Hig Rada Toksikol. 2010 Jun 1;61(2):241-245.
Rogulj D et all.
Hyperkalaemia arises due to ace inhibitor in elderly patients
Expert Rev Neurother. 2010 Jul;10(7):1175-200.
Maayan L, Correll CU.
Weight gain management of antipsychotics
Rev Saude Publica. 2010 Jun 25. pii: S0034-89102010005000021. [Epub ahead of print]
Pinto CD et all.
Medicine prices and availability in the Brazilian Popular Pharmacy Program
Indian J Pharm Sci. 2009 May;71(3):331-5.
Arayne MS et all.
Metformin performance in pharmacy formulas
Indian J Pharm Sci. 2009 May;71(3):318-20.
Kar M, Choudhury PK.
Estimation of metformin in microsphere and tablets
West Indian Med J. 2009 Nov;58(5):433-6.
Sohrabvand F et all.
How metformin reacts in pregnant patients at the time of miscarriage
Equine Vet J. 2009 Dec;41(9):924-9.
Durham AE et all.
Study on horses depicting the dysfunctioning of type 2 diabetes mellitus
Norris SL et all.
Portland (OR): Oregon Health & Science University; 2008. Drug Class Reviews.
The final report of Thiazolidinediones drug class
West J Emerg Med. 2008 Aug;9(3):160-4.
Suchard JR, Grotsky TA.
Results of overdose while taking metformin
J Indian Med Assoc. 2008 Oct;106(10):643-4, 646-8.
Chaudhury K et all.
Analysis of metformin augmenting the ovulation in non obese women
Nig Q J Hosp Med. 2008 Oct-Dec;18(4):211-5.
Adeneye AA.
Impact of rutaceae in diabetec rats
Drug Class Reviews.
McDonagh M et all.
Combination of pharmacy for type 2 diabetes patients
Journ Annu Diabetol Hotel Dieu. 2007:13-20.
Holman R.
Metformin for the treatment of diabetes
Med J Malaysia. 2007 Oct;62(4):294-8.
Dinesh KU et all.
Department of Hospital and Clinical Pharmacy/Pharmacology, Manipal Teaching Hospital / Manipal College of Medical Sciences, Pokhara, Nepal. dinesh17dec@rediffmail.com
Study of drug interaction in diabetic patients
Diabetes Technol Ther. 2009 Jun;11(6):379-83.
Karagiannis E et all.
Competact improves metabolic markers in diabetes patients
Competact review article...
|
My Basket
